
1. curr drug metab. 2006 feb;7(2):135-46.

prediction drug-drug interactions aucoral high clearance drug in
vitro data: utilization microtiter plate assay dispersion model.

yamamoto t(1), suzuki a, kohno y, nagata k, yamazoe y.

author information: 
(1)drug metabolism laboratory, medicinal development research laboratories,
taisho pharmaceutical co., ltd., 403, yoshino-cho 1-chome, kita-ku, saitama-shi, 
saitama 331-9530, japan. takahito.yamamoto@po.rd.taisho.co.jp

the purpose study propose new method predict vivo
drug-drug interactions (ddis) high clearance drug vitro data. as
the high clearance drug, ne-100 (n,
n-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride)
was used. first, approach based i(u)/k(i) value used prediction of
ddis ne-100 concomitant drugs. k(i) values (k(i-cal))
obtained microtiter plate (mtp) assay reported k(i) values
(k(i-rep)) drugs used predict increases levels ne-100
auc(oral) (auc(oral) ratio), auc(oral) ratios i(u)/k(i-cal)
correlated i(u)/k(i-rep). result suggests the
k(i-cal) mtp assay used prediction ddis instead the
k(i-rep) value. second, new approach combining inhibition rate (r)
calculated mtp assay two physiological models used predict
ddis. auc(oral) ratios ne-100 various drugs predicted using
the r value well-stirred model, ratios similar those
predicted using i(u)/k(i). however, co-administration drugs 
quinidine, propafenone thioridazine (potent inhibitors cyp2d6), ne-100
auc(oral) ratios predicted dispersion model much greater 
from well-stirred model. result shows application dispersion
model prediction method using r value might sensitively precisely 
predict increased levels auc(oral) ddis high clearance drug,
compared prediction method using i(u)/k(i) value.

doi: 10.2174/138920006775541570 
pmid: 16472104  [indexed medline]

